Sapporo Clinical Laboratory
9776.T
Financials · Standalone
| Fiscal year ended | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 | 2020-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥17.9bn | ¥17.3bn | ¥17.6bn | ¥17.7bn | ¥16.4bn | ¥16.5bn |
| Operating income | ¥540m | ¥369m | ¥705m | ¥1.5bn | ¥1.1bn | — |
| Ordinary income | ¥719m | ¥598m | ¥895m | ¥1.6bn | ¥1.2bn | ¥944m |
| Total assets | ¥15.0bn | ¥15.1bn | ¥14.5bn | ¥14.4bn | ¥13.7bn | ¥10.7bn |
| Net assets / equity | ¥10.9bn | ¥10.6bn | ¥10.2bn | ¥9.8bn | ¥9.0bn | ¥8.2bn |
| EPS (basic) | ¥152.24 | ¥138.25 | ¥141.47 | ¥300.67 | ¥231.1 | ¥147.04 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 2
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2025-09-30 | Half-year | 67 figures · EDINET |
| 2024-04-01 → 2025-03-31 | Annual | 197 figures · EDINET |
21 more reports are still being processed.
Segments · FY ended 2025-03
| Segment | External sales | Profit |
|---|---|---|
| Clinical Testing Business | ¥7.8bn | ¥255m |
| Dispensing Pharmacy Business | ¥11.3bn | ¥742m |
| Medical Devices Sales And Maintenance Business | ¥874m | −¥4m |
| Other segments | ¥166m | ¥125m |
| Total | ¥20.0bn | ¥993m |
| Total | ¥20.1bn | ¥1.1bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.